Trademark search
The 50 closest matches for of record for one firm.
| Mark | Status | Office | Owner | Classes | Filed |
|---|---|---|---|---|---|
| BUNKER | examining | USPTO | Draper Tools Limited | 9, 12, 18, 20 | 2026-10-13 |
| GROW-PEPTIDE | examining | USPTO | Amorepacific Corporation | 5 | 2026-10-12 |
| BIGFOOT BOWLS | examining | USPTO | F&S Produce Co., Inc. | 29 | 2026-10-12 |
| LABO-H PEPTIDE-6 LONGEVITY FORMULA | examining | USPTO | Amorepacific Corporation | 3 | 2026-10-09 |
| [Design Mark] | examining | USPTO | Bagpy, Co. | 16, 21 | 2026-10-07 |
| [Design Mark] | examining | USPTO | Amorepacific Corporation | 3 | 2026-10-07 |
| [Design Mark] | examining | USPTO | Amorepacific Corporation | 3 | 2026-10-07 |
| [Design Mark] | examining | USPTO | Amorepacific Corporation | 3 | 2026-10-07 |
| [Design Mark] | examining | USPTO | Amorepacific Corporation | 3 | 2026-10-07 |
| [Design Mark] | examining | USPTO | Amorepacific Corporation | 3 | 2026-10-07 |
| [Design Mark] | examining | USPTO | Amorepacific Corporation | 3 | 2026-10-07 |
| [Design Mark] | examining | USPTO | Amorepacific Corporation | 3 | 2026-10-07 |
| [Design Mark] | examining | USPTO | Amorepacific Corporation | 3 | 2026-10-07 |
| [Design Mark] | examining | USPTO | Amorepacific Corporation | 3 | 2026-10-07 |
| [Design Mark] | examining | USPTO | Amorepacific Corporation | 3 | 2026-10-07 |
| [Design Mark] | examining | USPTO | Amorepacific Corporation | 3 | 2026-10-07 |
| BYRTREYA | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-06 |
| DAYVELTRI | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-06 |
| DAZVELTRI | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-06 |
| GEMDAYLA | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-06 |
| GOVEYZA | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-06 |
| MIBURKI | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-06 |
| MYBURKI | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-06 |
| NUSILVA | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-06 |
| QYTREE | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-06 |
| VELBIRTRY | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-06 |
| ZERDAZLA | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-06 |
| BARKTRI | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-05 |
| BLUMVERIO | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-05 |
| BLUVELTI | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-05 |
| BLUZERIA | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-05 |
| BURTRI | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-05 |
| CAZKIVO | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-05 |
| DAZBERI | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-05 |
| DEYRIVTI | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-05 |
| EVBARKA | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-05 |
| KYSCOVIA | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-05 |
| TAMBYRIA | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-05 |
| VAYLZEYA | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-05 |
| RIADRIZ | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-01 |
| TYVLAFRI | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-01 |
| HYMAJEZ | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-01 |
| KAJIMORE | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-01 |
| KAVARMIK | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-01 |
| RALKABE | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-01 |
| RAYLIBNO | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-01 |
| SKIATEZ | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-01 |
| TURINVEY | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-10-01 |
| CLAZLERY | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-09-30 |
| CLURDUAD | examining | USPTO | Regeneron Pharmaceuticals, Inc. | 5 | 2026-09-30 |